We have previously shown that the MAPK activated protein kinase 2 (MK2) pathway is responsible for the majority of IL-1β, IL-6, and TNF-α production in both a colitis-associated cancer and a tumor transfer model of CRC (9, 10). The gene discussed is IL6; the disease is colorectal carcinoma.